Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

This study has been completed.
Sponsor:
Information provided by:
Grupo de Estudos Multicentricos em Onco-Hematologia
ClinicalTrials.gov Identifier:
NCT01296503
First received: January 27, 2011
Last updated: February 14, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)